ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE)

Preptin; Proinsulin-Like Growth Factor-II

  • ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) Packages (Simulation)
  • ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) Packages (Simulation)
  • ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) Results demonstration
  • CEA707Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Specificity of the ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE)

This assay has high sensitivity and excellent specificity for detection of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE).
No significant cross-reactivity or interference between Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) and analogues was observed.

Recovery of the ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE)

Matrices listed below were spiked with certain level of recombinant Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) and the recovery rates were calculated by comparing the measured value to the expected amount of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 86-97 91
EDTA plasma(n=5) 87-96 91
heparin plasma(n=5) 91-102 96

Precision of the ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE)

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity of the ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE)

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 82-101% 97-104% 86-96% 83-104%
EDTA plasma(n=5) 94-102% 99-105% 78-99% 80-95%
heparin plasma(n=5) 80-104% 87-102% 78-90% 78-101%

Stability of the ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE)

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary of the ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE)

1. Prepare all reagents, samples and standards;
2. Add 50µL standard or sample to each well.
    And then add 50µL prepared Detection Reagent A immediately.
    Shake and mix. Incubate 1 hour at 37°C;
3. Aspirate and wash 3 times;
4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
5. Aspirate and wash 5 times;
6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
7. Add 50µL Stop Solution. Read at 450 nm immediately.

Test principle of the ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE)

This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) and unlabeled Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) (Standards or samples) with the pre-coated antibody specific to Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) in the sample. After addition of the substrate solution, the intensity of color developed is reverse proportional to the concentration of Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) in the sample.

Related products

Catalog No. Organism species: Homo sapiens (Human) Applications (RESEARCH USE ONLY!)
CEA707Hu ELISA Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA707Hu Multiplex Assay Kit for Pro-Insulin Like Growth Factor II E-Peptide (IGFIIE) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.
GUESTBOOK